{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:28:42Z","timestamp":1786973322415,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research (B) from the Ministry of Education, Science and Culture of Japan","award":["23H02773"],"award-info":[{"award-number":["23H02773"]}]},{"name":"Scientific Research (B) from the Ministry of Education, Science and Culture of Japan","award":["25K02533"],"award-info":[{"award-number":["25K02533"]}]},{"name":"Scientific Research (C) from the Ministry of Education, Science and Culture of Japan","award":["23K06768"],"award-info":[{"award-number":["23K06768"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-54691-x","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:23:24Z","timestamp":1780604604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Generation of anti-bovine CD20 monoclonal antibody with cytotoxic activity for the depletion of bovine B-cell lymphoma cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Shuya","family":"Mitoma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomofumi","family":"Uto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Fukaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Yamanokuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yotaro","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Wakitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Fuke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Kitahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"54691_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ani14020297","volume":"14","author":"G Lv","year":"2024","unstructured":"Lv, G., Wang, J., Lian, S., Wang, H. & Wu, R. The global epidemiology of bovine leukemia virus: Current trends and future implications. Animals 14, 297. https:\/\/doi.org\/10.3390\/ani14020297 (2024).","journal-title":"Animals"},{"key":"54691_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-4-18","volume":"4","author":"N Gillet","year":"2007","unstructured":"Gillet, N. et al. Mechanisms of leukemogenesis induced by bovine leukemia virus: Prospects for novel anti-retroviral therapies in human. Retrovirology 4, 18. https:\/\/doi.org\/10.1186\/1742-4690-4-18 (2007).","journal-title":"Retrovirology"},{"key":"54691_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0378-1135(88)90066-1","volume":"17","author":"A Burny","year":"1988","unstructured":"Burny, A. et al. Bovine leukaemia: Facts and hypotheses derived from the study of an infectious cancer. Vet. Microbiol. 17, 197\u2013218 (1988).","journal-title":"Vet. Microbiol."},{"key":"54691_CR4","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1292\/jvms.14-0624","volume":"77","author":"H Mekata","year":"2015","unstructured":"Mekata, H. et al. Horizontal transmission and phylogenetic analysis of bovine leukemia virus in two districts of Miyazaki, Japan. J. Vet. Med. Sci. 77, 1115\u20131120 (2015).","journal-title":"J. Vet. Med. Sci."},{"key":"54691_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/vr.102464","volume":"176","author":"H Mekata","year":"2015","unstructured":"Mekata, H. et al. Evaluation of the natural perinatal transmission of bovine leukaemia virus. Vet. Rec. 176, 254. https:\/\/doi.org\/10.1136\/vr.102464 (2015).","journal-title":"Vet. Rec."},{"key":"54691_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.prevetmed.2021.105528","volume":"198","author":"S Nakada","year":"2022","unstructured":"Nakada, S., Fujimoto, Y., Kohara, J., Adachi, Y. & Makita, K. Estimation of economic loss by carcass weight reduction of Japanese dairy cows due to infection with bovine leukemia virus. Prev. Vet. Med. 198, 105528. https:\/\/doi.org\/10.1016\/j.prevetmed.2021.105528 (2022).","journal-title":"Prev. Vet. Med."},{"key":"54691_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.prevetmed.2016.09.011","volume":"133","author":"O Nekouei","year":"2016","unstructured":"Nekouei, O., VanLeeuwen, J., Stryhn, H., Kelton, D. & Keefe, G. Lifetime effects of infection with bovine leukemia virus on longevity and milk production of dairy cows. Prev. Vet. Med. 133, 1\u20139. https:\/\/doi.org\/10.1016\/j.prevetmed.2016.09.011 (2016).","journal-title":"Prev. Vet. Med."},{"key":"54691_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.980514","volume":"13","author":"G Su\u00e1rez Archilla","year":"2022","unstructured":"Su\u00e1rez Archilla, G. et al. A safe and effective vaccine against bovine leukemia virus. Front. Immunol. 13, 980514. https:\/\/doi.org\/10.3389\/fimmu.2022.980514 (2022).","journal-title":"Front. Immunol."},{"key":"54691_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2021.06.010","volume":"562","author":"H Murakami","year":"2021","unstructured":"Murakami, H. et al. Specific antiviral effect of violaceoid E on bovine leukemia virus. Virology 562, 1\u20138 (2021).","journal-title":"Virology"},{"key":"54691_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174916","volume":"12","author":"A Nishimori","year":"2017","unstructured":"Nishimori, A. et al. In vitro and in vivo antivirus activity of an anti-programmed death-ligand 1 (PD-L1) rat-bovine chimeric antibody against bovine leukemia virus infection. PLoS ONE 12, e0174916. https:\/\/doi.org\/10.1371\/journal.pone.0174916 (2017).","journal-title":"PLoS ONE"},{"key":"54691_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13567-023-01213-6","volume":"54","author":"T Okagawa","year":"2023","unstructured":"Okagawa, T. et al. Development of a high-affinity anti-bovine PD-1 rabbit-bovine chimeric antibody using an efficient selection and large production system. Vet. Res. 54, 82. https:\/\/doi.org\/10.1186\/s13567-023-01213-6 (2023).","journal-title":"Vet. Res."},{"key":"54691_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/icb.2015.48","volume":"94","author":"L Eon Kuek","year":"2016","unstructured":"Eon Kuek, L., Leffler, M., Mackay, G. A. & Hulett, M. D. The MS4A family: Counting past 1, 2 and 3. Immunol. Cell Biol. 94, 11\u201323. https:\/\/doi.org\/10.1038\/icb.2015.48 (2016).","journal-title":"Immunol. Cell Biol."},{"key":"54691_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00163","volume":"8","author":"TM Pierpont","year":"2018","unstructured":"Pierpont, T. M., Limper, C. B. & Richards, K. L. Past, present, and future of Rituximab-the world\u2019s first oncology monoclonal antibody therapy. Front. Oncol. 8, 163. https:\/\/doi.org\/10.3389\/fonc.2018.00163 (2018).","journal-title":"Front. Oncol."},{"key":"54691_CR14","doi-asserted-by":"publisher","first-page":"18545","DOI":"10.1074\/jbc.M800784200","volume":"283","author":"MJ Polyak","year":"2008","unstructured":"Polyak, M. J., Li, H., Shariat, N. & Deans, J. P. CD20 homo-oligomers physically associate with the B cell antigen receptor. Dissociation upon receptor engagement and recruitment of phosphoproteins and calmodulin-binding proteins. J. Biol. Chem. 283, 18545\u201318552 (2008).","journal-title":"J. Biol. Chem."},{"key":"54691_CR15","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3324\/haematol.2019.243543","volume":"105","author":"G Pavlasova","year":"2020","unstructured":"Pavlasova, G. & Mraz, M. The regulation and function of CD20: An \u201cenigma\u201d of B-cell biology and targeted therapy. Haematologica 105, 1494\u20131506 (2020).","journal-title":"Haematologica"},{"key":"54691_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/imr.13265","volume":"319","author":"CM Van Wagoner","year":"2023","unstructured":"Van Wagoner, C. M. et al. Antibody-mediated phagocytosis in cancer immunotherapy. Immunol. Rev. 319, 128\u2013141 (2023).","journal-title":"Immunol. Rev."},{"key":"54691_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-immunol-083122-044829","volume":"42","author":"I Abeles","year":"2024","unstructured":"Abeles, I. et al. B cell-directed therapy in autoimmunity. Annu. Rev. Immunol. 42, 103\u2013126 (2024).","journal-title":"Annu. Rev. Immunol."},{"key":"54691_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12325-016-0451-1","volume":"34","author":"K Tobinai","year":"2017","unstructured":"Tobinai, K., Klein, C., Oya, N. & Fingerle-Rowson, G. A review of Obinutuzumab (GA101), a novel type II anti-CD20 monoclonal antibody, for the treatment of patients with B-cell malignancies. Adv. Ther. 34, 324\u2013356 (2017).","journal-title":"Adv. Ther."},{"key":"54691_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0302868","volume":"19","author":"K Murakami","year":"2024","unstructured":"Murakami, K. et al. Serum bta-miRNA-375 as a potential biomarker for the early diagnosis of enzootic bovine leukosis. PLoS ONE 19, e0302868. https:\/\/doi.org\/10.1371\/journal.pone.0302868 (2024).","journal-title":"PLoS ONE"},{"key":"54691_CR20","first-page":"199","volume":"67","author":"A Hagiwara","year":"2014","unstructured":"Hagiwara, A., Saito, M., Ishikawa, Y. & Kadota, K. A histological study of lymphoid neoplasms in cattle infected with bovine leukosis virus. Japan Med. Assoc. J. 67, 199\u2013203 (2014).","journal-title":"Japan Med. Assoc. J."},{"key":"54691_CR21","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1182\/blood-2008-10-183145","volume":"113","author":"K Sato","year":"2009","unstructured":"Sato, K. et al. Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease. Blood 113, 4780\u20134789. https:\/\/doi.org\/10.1182\/blood-2008-10-183145 (2009).","journal-title":"Blood"},{"key":"54691_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/cyto.a.24683","volume":"103","author":"EO Roos","year":"2023","unstructured":"Roos, E. O. et al. OMIP-085: Cattle B-cell phenotyping by an 8-color panel. Cytometry A. 103, 12\u201315 (2023).","journal-title":"Cytometry A."},{"key":"54691_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","volume":"38","author":"S Kesavardhana","year":"2020","unstructured":"Kesavardhana, S., Malireddi, R. K. S. & Kanneganti, T. D. Caspases in cell death, inflammation, and pyroptosis. Annu. Rev. Immunol. 38, 567\u2013595 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"54691_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/cdd.2012.149","volume":"20","author":"T Imao","year":"2013","unstructured":"Imao, T. & Nagata, S. Apaf-1- and caspase-8-independent apoptosis. Cell Death Differ. 20, 343\u2013352 (2013).","journal-title":"Cell Death Differ."},{"key":"54691_CR25","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nm1263","volume":"11","author":"G Kroemer","year":"2005","unstructured":"Kroemer, G. & Martin, S. Caspase-independent cell death. Nat. Med. 11, 725\u2013730 (2005).","journal-title":"Nat. Med."},{"key":"54691_CR26","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1182\/blood-2010-07-296913","volume":"117","author":"W Alduaij","year":"2011","unstructured":"Alduaij, W. et al. Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies. Blood 117, 4519\u20134529 (2011).","journal-title":"Blood"},{"key":"54691_CR27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature08710","volume":"463","author":"T Kirkegaard","year":"2010","unstructured":"Kirkegaard, T. et al. Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology. Nature 463, 549\u2013553 (2010).","journal-title":"Nature"},{"key":"54691_CR28","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1016\/j.molimm.2007.06.151","volume":"44","author":"MJ Glennie","year":"2007","unstructured":"Glennie, M. J., French, R. R., Cragg, M. S. & Taylor, R. P. Mechanisms of killing by anti-CD20 monoclonal antibodies. Mol. Immunol. 44, 3823\u20133837 (2007).","journal-title":"Mol. Immunol."},{"key":"54691_CR29","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1158\/1535-7163.MCT-12-1182","volume":"12","author":"S Herter","year":"2013","unstructured":"Herter, S. et al. Preclinical activity of the type II CD20 antibody GA101 (obinutuzumab) compared with rituximab and ofatumumab in vitro and in xenograft models. Mol. Cancer Ther. 12, 2031\u20132042 (2013).","journal-title":"Mol. Cancer Ther."},{"key":"54691_CR30","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1182\/blood-2009-06-225979","volume":"115","author":"E M\u00f6ssner","year":"2010","unstructured":"M\u00f6ssner, E. et al. Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity. Blood 115, 4393\u20134402 (2010).","journal-title":"Blood"},{"key":"54691_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00262-001-0247-1","volume":"51","author":"PM Cardarelli","year":"2002","unstructured":"Cardarelli, P. M. et al. Binding to CD20 by anti-B1 antibody or F(ab\u2019)(2) is sufficient for induction of apoptosis in B-cell lines. Cancer Immunol. Immunother. 51, 15\u201324 (2002).","journal-title":"Cancer Immunol. Immunother."},{"key":"54691_CR32","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1046\/j.1365-2567.2002.01495.x","volume":"107","author":"JP Deans","year":"2002","unstructured":"Deans, J. P., Li, H. & Polyak, M. J. CD20-mediated apoptosis: Signalling through lipid rafts. Immunology 107, 176\u2013182 (2002).","journal-title":"Immunology"},{"key":"54691_CR33","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.ctrv.2015.05.007","volume":"41","author":"D P\u00e9rez-Callejo","year":"2015","unstructured":"P\u00e9rez-Callejo, D., Gonz\u00e1lez-Rinc\u00f3n, J., S\u00e1nchez, A., Provencio, M. & S\u00e1nchez-Beato, M. Action and resistance of monoclonal CD20 antibodies therapy in B-cell Non-Hodgkin Lymphomas. Cancer Treat. Rev. 41, 680\u2013689 (2015).","journal-title":"Cancer Treat. Rev."},{"key":"54691_CR34","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1158\/1541-7786.MCR-11-0154","volume":"9","author":"C Bezombes","year":"2011","unstructured":"Bezombes, C., Fourni\u00e9, J. J. & Laurent, G. Direct effect of rituximab in B-cell-derived lymphoid neoplasias: Mechanism, regulation, and perspectives. Mol. Cancer Res. 9, 1435\u20131442 (2011).","journal-title":"Mol. Cancer Res."},{"key":"54691_CR35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.critrevonc.2015.09.001","volume":"97","author":"N Seyfizadeh","year":"2016","unstructured":"Seyfizadeh, N., Seyfizadeh, N., Hasenkamp, J. & Huerta-Yepez, S. A molecular perspective on rituximab: A monoclonal antibody for B cell non Hodgkin lymphoma and other affections. Crit. Rev. Oncol. Hematol. 97, 275\u2013290 (2016).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"54691_CR36","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1182\/blood-2011-12-395541","volume":"119","author":"J Honeychurch","year":"2012","unstructured":"Honeychurch, J. et al. Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway. Blood 119, 3523\u20133533 (2012).","journal-title":"Blood"},{"key":"54691_CR37","first-page":"2143","volume":"119","author":"A Ivanov","year":"2009","unstructured":"Ivanov, A. et al. Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells. J. Clin. Invest. 119, 2143\u20132159 (2009).","journal-title":"J. Clin. Invest."},{"key":"54691_CR38","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1182\/blood-2001-12-0217","volume":"100","author":"V Mateo","year":"2002","unstructured":"Mateo, V. et al. Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: Link between phosphatidylserine exposure and cytoskeleton organization. Blood 100, 2882\u20132890 (2002).","journal-title":"Blood"},{"key":"54691_CR39","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1182\/blood-2011-09-381988","volume":"119","author":"P Gupta","year":"2012","unstructured":"Gupta, P. et al. Dual-targeting immunotherapy of lymphoma: Potent cytotoxicity of anti-CD20\/CD74 bispecific antibodies in mantle cell and other lymphomas. Blood 119, 3767\u20133778 (2012).","journal-title":"Blood"},{"key":"54691_CR40","doi-asserted-by":"publisher","first-page":"5664","DOI":"10.1038\/sj.onc.1207741","volume":"23","author":"V Cerisano","year":"2004","unstructured":"Cerisano, V. et al. Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing\u2019s sarcoma cells: Actin and zyxin as key intracellular mediators. Oncogene 23, 5664\u20135674 (2004).","journal-title":"Oncogene"},{"key":"54691_CR41","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","volume":"100","author":"M Ito","year":"2002","unstructured":"Ito, M. et al. NOD\/SCID\/gamma(c)(null) mouse: An excellent recipient mouse model for engraftment of human cells. Blood 100, 3175\u20133182 (2002).","journal-title":"Blood"},{"key":"54691_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.532684","volume":"11","author":"I Katano","year":"2020","unstructured":"Katano, I., Ito, R., Kawai, K. & Takahashi, T. Improved detection of in vivo human NK cell-mediated antibody-dependent cellular cytotoxicity using a novel NOG-Fc\u03b3R-deficient human IL-15 transgenic mouse. Front. Immunol. 11, 532684. https:\/\/doi.org\/10.3389\/fimmu.2020.532684 (2020).","journal-title":"Front. Immunol."},{"key":"54691_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1292\/jvms.16-0354","volume":"79","author":"S Konnai","year":"2017","unstructured":"Konnai, S., Murata, S. & Ohashi, K. Immune exhaustion during chronic infections in cattle. J. Vet. Med. Sci. 79, 1\u20135 (2017).","journal-title":"J. Vet. Med. Sci."},{"key":"54691_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/iid3.93","volume":"4","author":"K Ohira","year":"2016","unstructured":"Ohira, K. et al. Bovine leukemia virus reduces anti-viral cytokine activities and NK cytotoxicity by inducing TGF-\u03b2 secretion from regulatory T cells. Immun. Inflamm. Dis. 4, 52\u201363 (2016).","journal-title":"Immun. Inflamm. Dis."},{"key":"54691_CR45","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4142\/jvs.2017.18.3.341","volume":"18","author":"M Yasuda","year":"2017","unstructured":"Yasuda, M., Kawabata, J., Akieda-Asai, S., Nasu, T. & Date, Y. Guanylyl cyclase C and guanylin reduce fat droplet accumulation in cattle mesenteric adipose tissue. J. Vet. Sci. 18, 341\u2013348 (2017).","journal-title":"J. Vet. Sci."},{"key":"54691_CR46","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1439-0450.1986.tb00073.x","volume":"33","author":"H Koyama","year":"1986","unstructured":"Koyama, H. et al. Establishment of a continuous cell line derived from leukaemic cattle. J. Vet. Med. B. 33, 586\u2013596 (1986).","journal-title":"J. Vet. Med. B."},{"key":"54691_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/v14050995","volume":"14","author":"MP Yamanaka","year":"2022","unstructured":"Yamanaka, M. P., Saito, S., Hosomichi, K. & Aida, Y. Comprehensive comparison of novel bovine leukemia virus (BLV) integration sites between B-cell lymphoma lines BLSC-KU1 and BLSC-KU17 using the viral DNA capture high-throughput sequencing method. Viruses 14, 995. https:\/\/doi.org\/10.3390\/v14050995 (2022).","journal-title":"Viruses"},{"key":"54691_CR48","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1439-0450.1992.tb01134.x","volume":"39","author":"H Koyama","year":"1992","unstructured":"Koyama, H. et al. Properties of nine continuous B-cell lines established from enzootic bovine leukosis tumors. J. Vet. Med. B. 39, 32\u201338 (1992).","journal-title":"J. Vet. Med. B."},{"key":"54691_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-024-06207-z","volume":"170","author":"S Ullah","year":"2024","unstructured":"Ullah, S. et al. Direct TaqMan assay for the detection and genotyping of bovine viral diarrhea virus types 1 and 2. Arch. Virol. 170, 15. https:\/\/doi.org\/10.1007\/s00705-024-06207-z (2024).","journal-title":"Arch. Virol."},{"key":"54691_CR50","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1292\/jvms.24-0470","volume":"87","author":"S Mitoma","year":"2025","unstructured":"Mitoma, S. et al. Selectivity of bovine interleukin-2 mutein stimulation on bovine peripheral blood mononuclear cells. J. Vet. Med. Sci. 87, 781\u2013790 (2025).","journal-title":"J. Vet. Med. Sci."},{"key":"54691_CR51","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/intimm\/dxaa034","volume":"32","author":"J Nasu","year":"2020","unstructured":"Nasu, J. et al. Pivotal role of the carbohydrate recognition domain in self-interaction of CLEC4A to elicit the ITIM-mediated inhibitory function in murine conventional dendritic cells in vitro. Int. Immunol. 32, 673\u2013682 (2020).","journal-title":"Int. Immunol."},{"key":"54691_CR52","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00705-004-0433-5","volume":"150","author":"Y Asfaw","year":"2005","unstructured":"Asfaw, Y. et al. Distribution and superinfection of bovine leukemia virus genotypes in Japan. Arch Virol. 150, 493\u2013505 (2005).","journal-title":"Arch Virol."},{"key":"54691_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2052.1992.tb00168.x","volume":"23","author":"MJ van Eijk","year":"1992","unstructured":"van Eijk, M. J., Stewart-Haynes, J. A. & Lewin, H. A. Extensive polymorphism of the BoLA-DRB3 gene distinguished by PCR-RFLP. Anim. Genet. 23, 483 (1992).","journal-title":"Anim. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54691-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54691-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54691-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:04:16Z","timestamp":1786971856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54691-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54691"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54691-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25640"}}